Enable Biosciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Enable Biosciences's estimated annual revenue is currently $2.5M per year.(i)
  • Enable Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Enable Biosciences has 16 Employees.(i)
  • Enable Biosciences grew their employee count by 23% last year.

Enable Biosciences's People

NameTitleEmail/Phone
1
CEO / CFO / CMOReveal Email/Phone
2
Co-founder and CSOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Co-Founder and Chief Operating OfficerReveal Email/Phone
5
Laboratory DirectorReveal Email/Phone
6
Senior DirectorReveal Email/Phone
7
Co-Founder and Chief Technology OfficerReveal Email/Phone
8
Director, Laboratory Operations and AutomationReveal Email/Phone
9
Client Relations ManagerReveal Email/Phone
10
Laboratory AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Enable Biosciences?

Enable Biosciences is a South San Francisco-based diagnostics company. We develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Enable Biosciences News

2022-04-17 - Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys Therapeutics

Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of ... which will enable us to manufacture these therapies internally and...

2022-04-17 - Labcorp Enhances Cell and Gene Therapy Development ...

“The exciting projects we're undertaking with Labcorp allow our shared clients to harness the institutional ... About Xcell Biosciences

2022-04-06 - Curate Biosciences and City of Hope Evaluate Innovative Cell ...

Curate Biosciences' cell separation platform has the potential to enable up to a 50% reduction in the total cost of autologous cell therapy...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M16-78%$187.1M
#2
$2M16220%N/A
#3
$1.4M18-25%$35M
#4
$3.1M18-10%N/A
#5
$2.8M18-10%N/A